Searched for
MULTINATIONAL PHARMACEUTICAL COMPANIES
These mid-cap stocks with ‘Strong Buy’ & ‘Buy’ recos can rally over 25%, according to analystsGiven the state of the market these days, it would be wise to be selective. Not only in terms of stocks, but also in terms of sectors. For ...- Hyderabad is India's most expensive GCC office market, commands 15% premiumHyderabad has emerged as India's priciest office market for Global Capability Centres (GCCs), commanding a 15% premium. The city leads the ...
- India Inc's green transition triggers hiring surgeAs organisations step up their sustainability efforts, demand is also growing for senior leadership talent, including business heads for re...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
- Healthium Medtech CEO Anish Bafna steps down, moves to non-executive chairman roleHealthium Medtech's CEO Anish Bafna is transitioning to non-executive chairman as KKR-owned company seeks a new chief within a month. Bafna...
- Smaller cities power India’s corporate travel surgeCorporate travel in India is increasingly shifting towards smaller cities, with nearly 60% of bookings now originating from or heading to t...
- More women CXOs join India’s million-dollar pay club as domestic firms lead compensation growthNine women now earn over one million dollars annually as C-suite executives. Domestic companies are leading this rise, reflecting a focus o...
- Wockhardt shares jump 8%, extend rally after CDSCO nod for Zaynich antibioticWockhardt shares surged after the company received CDSCO approval for its breakthrough antibiotic Zaynich in India. Strong Phase 3 trial re...
- Time to think of the repair cycle? 8 engineering stocks from India’s capital goods ecosystem with upside potential of up to 26%At a time when the markets are focused on war, crude oil, inflation, and supply disruption, it is easy to miss a quieter shift. India’s eng...
- From ₹5,000 salary to ₹48 crore turnover: Meet Nayana Vaidya, a pharma saleswoman, who built a healthcare distribution company from scratchNayana Vaidya built Om Sai Surgicals from a modest beginning. Her company achieved a turnover of nearly ₹48 crore. Vaidya finds satisfactio...
- Citi sees India IPOs hitting fresh records despite challengesIndian initial public offerings are poised for a strong comeback in the latter half of the year. Citigroup anticipates deal volumes to meet...
- Novartis sharpening India strategy as a pure-play innovatorNovartis India country president and managing director Amitabh Dube said India is gradually moving beyond its traditional role as a clinica...
- India’s 'China-plus-one' push needs tax ease and fast-track FTAs with developed nations: Arvind VirmaniIndia must reform its tax system and streamline clearances to attract global investments moving away from China. Economist Arvind Virmani e...
- Hospitals warn Central Government Health Scheme reimbursement cap may hurt cancer treatmentA major private hospital group warns of a crisis for advanced cancer patients under the Central Government Health Scheme. A reimbursement c...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- Aurobindo Pharma approves Rs 800 crore share buyback. Check record date, other key detailsAurobindo Pharma is launching its first share buyback in two years, offering to repurchase over 54 lakh shares at Rs 1,475 each. This tende...
- Pharma MNCs may change strategies post Sun Pharma-Ranbaxy dealThe deal may dispel government concerns that allowing overseas investment in pharmaceutical companies would lead to a multinational monopol...
- Pharma sector in good health, to create more jobs: ExpertsIndian as well as multinational pharmaceutical companies are likely to create more jobs in 2014 on the back of expected double digit growth...
- Patents appeal board rejects AstraZeneca's plea on cancer drugPatents appeal board has dismissed AstraZeneca's petition challenging an earlier ruling that refused patent protection for a cancer-fightin...
- Govt gives diplomatic push to pharma exports to AfricaIndia has started a diplomatic exercise to counter a 'propaganda' by multinational pharmaceutical companies against Indian generics or off-...
Load More
